Are Antimicrobial Peptides a 21st-Century Solution for Atopic Dermatitis?
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms241713460 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Manuela Machado und 2 weiteren Autor:innen. Beteiligte Einrichtung: CBQF Centro de Biotecnologia e Química Fina Laboratório Associado, Escola Superior de Biotecnologia, Universidade Católica Portuguesa, Rua Diogo Bote…. Hauptthemen laut MEDLINE: Dermatitis, Atopic. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 153 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e Tecnologia.
Abstract (Originalsprache)
Atopic dermatitis (AD) is a chronic inflammatory skin disorder that is the result of various environmental, bacterial and genetic stimuli, which culminate in the disruption of the skin’s barrier function. Characterized by highly pruritic skin lesions, xerosis and an array of comorbidities among which skin infections are the most common, this condition results in both a significant loss of quality of life and in the need for life-long treatments (e.g., corticosteroids, monoclonal antibodies and regular antibiotic intake), all of which may have harmful secondary effects. This, in conjunction with AD’s rising prevalence, made the development of alternative treatment strategies the focus of both the scientific community and the pharmaceutical industry. Given their potential to both manage the skin microbiome, fight infections and even modulate the local immune response, the use of antimicrobial peptides (AMPs) from more diverse origins has become one of the most promising alternative solutions for AD management, with some being already used with some success towards this end. However, their production and use also exhibit some limitations. The current work seeks to compile the available information and provide a better understanding of the state of the art in the understanding of AMPs’ true potential in addressing AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CBQF Centro de Biotecnologia e Química Fina Laboratório Associado, Escola Superior de Biotecnologia, Universidade Católica Portuguesa, Rua Diogo Botelho 1327, 4169-005 Porto, Portugal.
ORCID-Profile: Manuela Machado, Sara Silva, Eduardo M Costa
Förderung
- Fundação para a Ciência e Tecnologia
Zitieren
APA
Machado, M., Silva, S., & Costa, E. M. (2023). Are Antimicrobial Peptides a 21st-Century Solution for Atopic Dermatitis?. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241713460
Vancouver
Machado M, Silva S, Costa EM. Are Antimicrobial Peptides a 21st-Century Solution for Atopic Dermatitis?. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241713460
BibTeX
@article{Machado2023,
author = {Machado, Manuela and Silva, Sara and Costa, Eduardo M},
title = {Are Antimicrobial Peptides a 21st-Century Solution for Atopic Dermatitis?},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms241713460}
}
EUVIMED